Richardson, Texas
CNS medication trials in Richardson, TX
24 CNS medication studies are recruiting participants at sites in Richardson as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Richardson at a glance
- 24 studies are recruiting at a site in Richardson.
- By phase: Phase 1 (3), Phase 2 (9), Phase 3 (12).
- By sponsor: industry (23), government (1).
- By research area: Schizophrenia (10), Depression (8), Bipolar Disorder (5), Multiple Sclerosis (1).
- Most recent update to one of these records: November 13, 2026.
Depression studies recruiting in Richardson
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Seaport Therapeutics
- Study site
- Seaport Investigator Site
- Registry record
- NCT07065240 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Pillar Clinical Research, LLC
- Registry record
- NCT05850689 · updated
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07300969 · updated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06830044 · updated
Brexanolone Lifting Outcomes Of Moms
- Phase 3
- Ages 15 to 45
- Female participants
- Sponsor
- Lipocine Inc.
- Study site
- Lipocine Investigational Site
- Registry record
- NCT07822321 · updated
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Pillar Clinical Research - Richardson /ID# 272821
- Registry record
- NCT06696755 · updated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Pillar Clinical Research
- Registry record
- NCT07494305 · updated
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Pillar Clinical Research - Richardson /ID# 276764
- Registry record
- NCT07276997 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Richardson, TX on ClinicalTrials.gov.
Schizophrenia studies recruiting in Richardson
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Study site
- Pillar Clinical Research, LLC
- Registry record
- NCT07565428 · updated
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Phase 1
- Ages 18 to 60
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Pillar Clinical Research, LLC
- Registry record
- NCT07615426 · updated
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- Phase 2
- Ages 18 to 60
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT07680946 · updated
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Pillar Clinical Research - Richardson
- Registry record
- NCT07686263 · updated
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Phase 1
- Ages 18 to 55
- All sexes
- Sponsor
- Leal Therapeutics, Inc
- Study site
- Pillar Clinical Research, LLC
- Registry record
- NCT07734493 · updated
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Pillar Clinical Research - Richardson /ID# 275715
- Registry record
- NCT07145918 · updated
52-week Open Label Safety-Tolerability Study
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Pillar Clinical Research
- Registry record
- NCT07369154 · updated
Randomized Withdrawal Study in Patients With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06961968 · updated
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Reviva Pharmaceuticals
- Study site
- Reviva site
- Registry record
- NCT05184335 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Richardson, TX on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Richardson
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study sites
- Pillar Clinical Research · Pillar Clinical Research - Richardson
- Registry record
- NCT06951711 · updated
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Pillar Clinical Research - Richardson
- Registry record
- NCT07286175 · updated
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Pillar Clinical Research - Richardson
- Registry record
- NCT07140913 · updated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Pillar Clinical Research - Richardson
- Registry record
- NCT06929273 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Pillar Clinical Research - Richardson
- Registry record
- NCT06951698 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Richardson, TX on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Richardson
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT Southwestern Clinical Center at Richardson/Plano
- Registry record
- NCT03816345 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Richardson, TX on ClinicalTrials.gov.
Ask about studies near Richardson
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
147 studies recruiting across 48 cities.
Houston
66 studies recruiting.
Austin
52 studies recruiting.
Dallas
36 studies recruiting.
San Antonio
25 studies recruiting.
DeSoto
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections